NCT06786351

Brief Summary

Though the application of thoracic endovascular aortic repair (TEVAR) for treatment of aortic pathology is expanding, there remains a gap in the literature examining how intraoperative "reduction or elimination of aortic impulse" (REAI) techniques, in particular the use of right atrial occlusion, may impact patient important clinical outcomes. This study aims to provide prospective data from a large cohort of TEVAR patients to explore clinical outcomes following TEVAR procedures and, specifically, whether right atrial occlusion has significant impact on clinical outcomes, as compared to other REAI techniques. The results from this study may inform future perioperative TEVAR practices and improve TEVAR patient outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
34mo left

Started Sep 2025

Typical duration for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress20%
Sep 2025Jan 2029

First Submitted

Initial submission to the registry

January 7, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

January 22, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

September 1, 2025

Completed
3.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2029

Last Updated

June 29, 2025

Status Verified

June 1, 2025

Enrollment Period

3.4 years

First QC Date

January 7, 2025

Last Update Submit

June 25, 2025

Conditions

Keywords

right atrial balloon occlusionthoracic endovascular aortic repairstent graft repairreduction of elimination of aortic impulse

Outcome Measures

Primary Outcomes (2)

  • Endoleak occurrence up to hospital discharge

    Endoleak occurrence prior to hospital discharge

    end of surgery to hospital discharge up to 10 days)

  • Endoleak occurrence to one-year post-surgery

    Endoleak occurrence within one-year of surgery

    end of surgery to one-year post-surgery

Secondary Outcomes (11)

  • Perioperative mortality to 30 days post-surgery

    post-surgery to 30 days post-surgery

  • All-cause mortality to one-year post-surgery

    post-surgery to one-year post-surgery

  • Complications: massive hemorrhage

    within 30 days post-surgery and at 1 year

  • Complications: cerebrovascular

    within 30 days post-surgery and at 1 year

  • Complications: spinal cord ischemia

    within 30 days post-surgery and at 1 year

  • +6 more secondary outcomes

Study Arms (2)

Right atrial balloon occlusion

Thoracic endovascular aortic repair with right atrial balloon occlusion for reduction or elimination of aortic impulse

Procedure: Right atrial balloon occlusion

Non right atrial balloon occlusion

Thoracic endovascular aortic repair not using right atrial balloon occlusion for reduction or elimination of aortic impulse

Procedure: Non right atrial balloon occlusion

Interventions

Thoracic endovascular aortic repair with right atrial balloon occlusion for reduction or elimination of aortic impulse and stent graft deployment in landing zones 0-3

Right atrial balloon occlusion

Thoracic endovascular aortic repair not using right atrial balloon occlusion for reduction or elimination of aortic impulse and stent graft deployment in landing zones 0-3

Non right atrial balloon occlusion

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients undergoing emergency or elective thoracic endovascular aortic repair at the Peter Lougheed Centre, Calgary, Alberta

You may qualify if:

  • age 18 years or older
  • thoracic endovascular aortic repair
  • right atrial balloon occlusion for reduction or elimination of aortic impulse
  • endograft deployment in landing zones 0-3

You may not qualify if:

  • age 18 years or younger
  • non-thoracic endovascular aortic repair
  • reduction or elimination of aortic impulse using technique other than right atrial balloon occlusion
  • endograft deployment in landing zones 4 and beyond

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Aortic Aneurysm, ThoracicDissection, Thoracic Aorta

Condition Hierarchy (Ancestors)

Aortic AneurysmAneurysmVascular DiseasesCardiovascular DiseasesAortic DiseasesAortic DissectionDissection, Blood VesselAcute Aortic Syndrome

Central Study Contacts

Claire Allen, MD, FRCPC

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Lecturer

Study Record Dates

First Submitted

January 7, 2025

First Posted

January 22, 2025

Study Start

September 1, 2025

Primary Completion (Estimated)

January 31, 2029

Study Completion (Estimated)

January 31, 2029

Last Updated

June 29, 2025

Record last verified: 2025-06